Drugs Made In America Acquisition Corp. (DMAA) Cash flow

2 Followers

Drugs Made In America Acquisition Corp. Cash Flow

DMAA's free cash flow for Q3 2025 was $137.90K. For the 2025 fiscal year, DMAA's free cash flow was decreased by $― and operating cash flow was $137.91K. See a summary of the company’s cash flow.

Cash Flow	Dec 24
Operating Cash Flow	$ -295.00
Investing Cash Flow	$ 0.00
Financing Cash Flow	$ 173.62K
End Cash Position	$ 1.35K
Free Cash Flow	$ -295.00

Currency in USD